期刊文献+

不同体积的亚甲蓝检测Ⅰ期乳腺癌前哨淋巴结的对比研究 被引量:3

Effect of different volumes of methyleneblue on detection of sentinel lymph node in one-stage breast cancer patients
下载PDF
导出
摘要 目的探讨不同体积的亚甲蓝注射液染色示踪法在Ⅰ期乳腺癌前哨淋巴结活检中的临床应用价值。方法回顾性分析自2010年1月至2015年6月,76例Ⅰ期乳腺癌病人,分低剂量组(0.2 mL),中剂量组(2 mL),高剂量组(4 mL)3组,使用1%亚甲蓝注射液为示踪剂,行术中前哨淋巴结活检术。结果 76例患者,成功施行75例前哨淋巴结活检术,检出率为98.7%,准确率为100%,阴性率为0。低剂量组并发症的发生率与另两组存在差异,其差异具有统计学意义。结论低剂量0.2 mL亚甲蓝示踪法在Ⅰ期乳腺癌前哨淋巴结中,准确性高,并发症少。 Objective To investigate the clinical application of methylene blue staining with different volume in the sentinel lymph node biopsy of one-stage breast cancer. Methods From January2010 to June 2015, 76 patients with one-stage breast cancer were divided into low dose group(0.2 ml),medium dose group(2 ml) and high dose group(4 ml). 1% methylene blue was injected as tracer, and sentinel lymph node biopsy was done. Results Among 76 cases, 75 cases were detected sentinel lymph node biopsy. The detection rate was 98.7%, the accuracy rate was 100% and false negative rate was 0.There were significant differences in the incidence of complications in the low dose group and the other two groups. Conclusion As a tracer, low dose of 1% methyleneblu showed higher accuracy and less complications in detecting sentinel lymph nodes in one-stage breast cancer patients.
出处 《岭南现代临床外科》 2016年第2期149-152,共4页 Lingnan Modern Clinics in Surgery
关键词 亚甲蓝 前哨淋巴结 乳腺癌 Methylene blue Sentinel lymph node Breast cancer
  • 相关文献

参考文献17

  • 1Miller CL, Specht MC, Skolny MN. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema : implications for prophylactic surgery [ J ]. Breast Cancer Res Treat, 2012, 135: 781-789.
  • 2Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer [J]. N Engl J Med, 2003, 349 (6) : 546-553.
  • 3Ahmed M. Sentinel lymph node identification rates and axillary concordance can only be accurately determined by comparing "like with like" injected materials [J]. Breast Cancer Res Treat, 2014, 146(1): 229-230.
  • 4Radovanovic Z, Golubovic A, Plzak A, et al. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer [J ]. Eur J Surg Oncol, 2004, 30(9): 913-917.
  • 5Fonti R, Limite G, Sodano A, et al. Sentinel lymph node identification in breast cancer patients [J]. Radiol Med, 2002, 103(4) : 370-377.
  • 6王永胜.乳腺癌前哨淋巴结活检的安全性[J].中国癌症杂志,2006,16(9):685-688. 被引量:28
  • 7Carlson RW, Allred DC, Anderson BO, et al. Breast cancer. Clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw, 2009, 7(2): 122-192.
  • 8周韬.乳腺癌前哨淋巴结的临床研究进展[J].中国肿瘤外科杂志,2014,6(1):44-47. 被引量:15
  • 9Tievarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer [J].Am J Surg, 2005, 189(2): 236-239.
  • 10Bezu C, Coutant C, Salengro A, et al. Anaphylactic response to blue dye during sentinel lymph node biopsy [J]. Surg Oncol, 2011, 20( 1 ) : e55-59.

二级参考文献64

  • 1王永胜,左文述,刘娟娟,于志勇,刘岩松,李永清,周正波,刘雁冰,李济宇,赵桐,陈鹏.乳腺癌前哨淋巴结活检替代腋窝清扫术前瞻性非随机对照临床研究[J].外科理论与实践,2006,11(2):104-107. 被引量:32
  • 2Fleissig A,Fallowfield LJ,Langridge CI,et al.Post-operative arm morbidity and quality of life.Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J].Breast Cancer Res Treat,2006,95 (3):279-293.
  • 3Edge SB,Niland JC,Bookman MA,et al.Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers[J].J Natl Cancer Inst,2003,95(20):1514-1521.
  • 4Mansel RE,Fallowfield L,Kissin M,et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer:the ALMANAC Trial[J].J Natl Cancer Inst.2006; 98 (9):599-609.
  • 5Purushotham AD,Upponi S,Klevesath MB,et al.Morbidity after sentinel lymph node biopsy in primary breast cancer:results from a randomized controlled trial[J].J Clin Oncol,2005,23(19):4312-4321.
  • 6Schulze T,Mucke J,Markwardt J,et al.Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection[J].J Surg Oncol,2006,93(2):109-119.
  • 7Rietman JS,Geertzen JH,Hoekstra HJ,et al.Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage Ⅰ or Ⅱ breast cancer[J].Eur J Surg Oncol,2006,32(2):148-152.
  • 8Martin RC,Chagpar A,Scoggins CR,et al.University of Louisville Breast Cancer Sentinel Lymph Node Study.Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer[J].Ann Surg,2005,241 (6):1005-1012;discussion 1012-1015.
  • 9Veronesi U,Paganelli G,Viale G,et al.A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003,349(6):546-553.
  • 10Julian TB,Krag D,Brown A,et al.Preliminary technical results of NSAPBP B-32,a randomized phase Ⅲ clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients[J].Breast Cancer Res Treat,2004,88(s1):s11-12.

共引文献45

同被引文献35

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部